Ergoteles’s Avenue Therapeutics ATXI Stock Holding History
Bought
Maintained
Sold
Other funds holding ATXI
Ergoteles's ATXI Position: Q3 2021 in Review
Ergoteles sold out of Avenue Therapeutics (ATXI) in Q3 2021, closing a stake of 27 shares — an estimated $76K sold.
Ergoteles first reported a position in ATXI in Q2 2021 and held it in 1 quarter. The position peaked at $76K in Q2 2021. 17 funds tracked by Wall St. Rank hold ATXI as of Q3 2021.
- Ergoteles reported no remaining Avenue Therapeutics position as of Q3 2021 after selling out during the quarter.
- Ergoteles sold 27 Avenue Therapeutics shares in Q3 2021, an estimated $76K.
- Ergoteles first reported a position in Avenue Therapeutics in Q2 2021 and held it in 1 quarter.
- Ergoteles's Avenue Therapeutics position peaked at $76K in Q2 2021.
- 17 funds tracked by Wall St. Rank held Avenue Therapeutics as of Q3 2021.
Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.